AI / data analytics / healthtech / informatics

Qureight platform image
#AI / data analytics / healthtech / informatics #AstraZeneca #Lung disease #Qureight

Qureight and AZ collaborate on lung disease research

Cambridge data analytics company Qureight has announced a multi-year strategic research collaboration with AstraZeneca. The agreement will allow AstraZeneca to use Qureight’s proprietary platform and artificial intelligence (AI) technology to conduct research across a range of complex lung diseases. It is hoped that this will help… Read More

#News

Scientist Loads Samples Into Mercury
#AI / data analytics / healthtech / informatics #Arrayjet #Assay development & optimisation #Chemspace #Collaboration #High throughput screening

Arrayjet announces collaboration with Chemspace

Arrayjet and Chemspace have agreed a partnership to augment and streamline Chemspace’s small molecule microarray (SMM) service offering. Chemspace’s compound libraries are now accessible through Arrayjet’s SMM CRO/CMO services for assay development, contract screening and contract array manufacturing. SMMs enable high-throughput screening of compound… Read More

#News

AI brain
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #EMA #Machine learning

EMA urges “human-centric approach” to AI in drug discovery

The European Medicines Association (EMA) has published a draft reflection paper outlining the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of medicines. The paper, which is now open for public consultation, reflects on principles relevant to the application… Read More

#News #Regulatory

Map of Latin America
#AI / data analytics / healthtech / informatics #Biomedical research #Genetics / genomics #Latin America and the Caribbean (LAC) #Lifebit

Partners tackle global health challenges through genomics

UK-based precision medicine software provider Lifebit has agreed partnerships with two population genomic initiatives in Mexico and Brazil to help diversify genomic research and reduce health inequality in Latin America. Lifebit’s platform provides a secure way for research organisations to access global biomedical data – helping… Read More

#News

#AI / data analytics / healthtech / informatics #Cancer research #Genetics / genomics #Oncology

Open science, genomics, and the quiet revolution in our approach to pharma

Listen to this article on the DDW Podcast: Evan Floden, CEO of Seqera Labs examines how data sharing platforms are impacting cancer and genomics research. The tide has been turning in the worlds of diagnostics and drug development. Bioinformatics and genetic sequencing are starting to be placed front and centre of… Read More

#Cancer Research #Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug design #Gero #Quantum computing

Study demonstrates power of quantum computing in drug design

In a new scientific paper, AI-driven biotech Gero has demonstrated the feasibility of applying quantum computing to drug design and generative chemistry. The research, published in Scientific Reports, outlines how a hybrid quantum-classical machine-learning model was used to interface between classical and quantum computational devices with… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trial design #Clinical trials #Oncology #Phase II trial

A third of clinical trials cancelled during Phase II

Analysis of 13,490 clinical trials finds almost a third have been cancelled during Phase II amidst an overall decline in clinical development productivity. Data analytics company Phesi has released the results of its mid-year global analysis of all clinical trials conducted in 2023 to date. Read More

#News #Trending News

AI drug discovery
#AI / data analytics / healthtech / informatics #Drug discovery #Funding #Investment #Recursion

Nvidia invests $50 million into Recursion for drug AI 

Recursion, a clinical stage company decoding biology to industrialise drug discovery, has announced a $50 million investment by NVIDIA, which was executed as a private investment in public equity (PIPE).   Recursion also announced plans to accelerate development of its AI foundation models for biology and chemistry,… Read More

#News

Female scientist
#AI / data analytics / healthtech / informatics #BC Platforms #Rare disease #Real world data

Harnessing real-world data for rare and orphan disease research

This paid-for advertorial by BC Platforms appeared in DDW Volume 24 – Issue 3, Summer 2023 The use of real-world data (RWD) is demonstrating significant potential to enhance rare and orphan disease clinical research and development. By incorporating data from sources such as electronic health records, medical claims, patient registries, and… Read More

#Exclusive Content

Big data concept image
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Data science #Machine learning

Big data – charting a new path to drug discovery and development

Listen to this article on the DDW Podcast: Tim Lowery, President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. Drug discovery and development timelines can span 10-15… Read More

#Exclusive Content

Ageing hands
#Age-related diseases (ARDs) #Ageing #AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #University of Edinburgh

AI algorithms find drugs that could combat ageing

Three drugs that could help stave off the effects of ageing have been discovered using artificial intelligence (AI), a study by Edinburgh researchers suggests. Findings suggest the drugs can safely remove defective cells – known as senescent cells – linked to conditions including cancer, Alzheimer’s disease… Read More

#News

Seed funding
#AI / data analytics / healthtech / informatics #Investment #Omics #Seed funding #SMi Systems #Start-ups

SMi discloses £6 million seed funding round

SMi Systems has disclosed a £6m ($7.6m) seed funding round to develop and prove the utility of its multi-omic platform for in vitro diagnosis and biomedical research. SMi hopes the technology will significantly accelerate the discovery of new therapeutics by biopharma companies and research institutions. Read More

#News #Start-up Zone

Cancer immuno-oncology
#AI / data analytics / healthtech / informatics #Bispecific Antibodies #Bispecific therapeutics #Cambridge Healthtech Institute #Cancer immunotherapy #Events #Immuno-oncology #Next generation sequencing

Immuno-Oncology Summit Europe 2023: Programme highlights 

From June 20-22, 2023, Cambridge Healthtech Institute hosted the seventh annual Immuno-Oncology Summit Europe in London. DDW’s Megan Thomas shares highlights from the event programmes.   Programmes   This year’s summit was made up of conference programmes, which included: Modulating the Tumour Microenvironment; Next-Generation Cell-Based Immunotherapies; Bispecific and Multi-Specific Antibody Therapeutics, and… Read More

#Cancer Research #Exclusive Content #Opinion

#AI / data analytics / healthtech / informatics #Covid-19 #Genomics #Machine learning #Microfluidics

New podcast: Reaching new heights with drug discovery

This is the latest episode of the free DDW narrated podcast, “Reaching new heights with drug discovery”. It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “High-throughput technologies: Reaching for the stars” and “… Read More

#News

MRI image
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Imaging #Machine learning

Avoid the five stumbling blocks for working with medical imaging

How can you reduce timelines for R&D? Tackle your enterprise’s siloed and disorganised imaging data. Maximise the value of data in your archives and stop spending weeks on mundane data-wrangling tasks. We’ve compiled a list of the top five stumbling blocks for working with medical imaging. This… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Imaging #Machine learning

5 reasons your organisation needs a modern medical imaging infrastructure

How can you reduce timelines for R&D? Tackle your enterprise’s siloed and disorganised imaging data. Maximise the value of data in your archives and stop spending weeks on mundane data-wrangling tasks. We’ve compiled a list of the top 5 stumbling blocks for working with medical imaging. This whitepaper digs into… Read More

#Resources